Title |
Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination
|
---|---|
Published in |
Immunologic Research, August 2016
|
DOI | 10.1007/s12026-016-8855-1 |
Pubmed ID | |
Authors |
Svetlana Blitshteyn, Jill Brook |
Abstract |
We describe a young woman who developed POTS with positive serum anti-NMDA receptor antibodies and no evidence of encephalitis after vaccination with HPV vaccine, Cervarix. Her symptoms improved significantly with immunomodulatory therapy and re-occurred after immunomodulatory therapy was stopped, suggesting an autoimmune etiology of POTS after vaccination. |
X Demographics
The data shown below were collected from the profiles of 53 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 8 | 15% |
United States | 3 | 6% |
United Kingdom | 2 | 4% |
Canada | 1 | 2% |
Thailand | 1 | 2% |
Vietnam | 1 | 2% |
Panama | 1 | 2% |
Unknown | 36 | 68% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 48 | 91% |
Scientists | 3 | 6% |
Practitioners (doctors, other healthcare professionals) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 49 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 8 | 16% |
Other | 6 | 12% |
Student > Doctoral Student | 6 | 12% |
Professor > Associate Professor | 4 | 8% |
Student > Master | 4 | 8% |
Other | 9 | 18% |
Unknown | 12 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 39% |
Biochemistry, Genetics and Molecular Biology | 3 | 6% |
Nursing and Health Professions | 3 | 6% |
Neuroscience | 3 | 6% |
Agricultural and Biological Sciences | 2 | 4% |
Other | 5 | 10% |
Unknown | 14 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2023.
All research outputs
#919,780
of 25,698,912 outputs
Outputs from Immunologic Research
#32
of 950 outputs
Outputs of similar age
#17,008
of 352,511 outputs
Outputs of similar age from Immunologic Research
#8
of 46 outputs
Altmetric has tracked 25,698,912 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 950 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,511 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.